Africa Corporate Wellness Market, by End User, 2018-2027
Global Arrhythmia Monitoring Devices market [2016-2024] by Application
By Application, the market is segmented into Tachycardia, Bradycardia, Atrial Fibrillation (A-fib), Ventricular Fibrillation (V-fib), Premature Ventricular Contractions (PVC), Conduction Disorders, and Application_Others (1990)
| Label | Tachycardia | Bradycardia | Atrial Fibrillation (A-fib) | Ventricular Fibrillation (V-fib) | Premature Ventricular Contractions (PVC) | Conduction Disorders | Application_Others |
|---|---|---|---|---|---|---|---|
| 1234.20 | 1234.20 USD Mn | 1012.30 USD Mn | 789.6 USD Mn | 697.5 USD Mn | 544.1 USD Mn | 369.5 USD Mn | 217.2 USD Mn |
| 1308.30 | 1308.30 USD Mn | 1053.90 USD Mn | 836.1 USD Mn | 738.1 USD Mn | 575.3 USD Mn | 390.8 USD Mn | 229.5 USD Mn |
| 1413.70 | 1413.70 USD Mn | 1120.70 USD Mn | 902.7 USD Mn | 796.3 USD Mn | 620 USD Mn | 421.4 USD Mn | 247.1 USD Mn |
| 1521.50 | 1521.50 USD Mn | 1189.20 USD Mn | 970.7 USD Mn | 855.3 USD Mn | 665.3 USD Mn | 452.5 USD Mn | 265 USD Mn |
| 1632.60 | 1632.60 USD Mn | 1263.00 USD Mn | 1040.60 USD Mn | 915.5 USD Mn | 709.4 USD Mn | 484.4 USD Mn | 282.6 USD Mn |
| 1746.90 | 1746.90 USD Mn | 1348.80 USD Mn | 1111.60 USD Mn | 976.7 USD Mn | 751.3 USD Mn | 511.8 USD Mn | 298.7 USD Mn |
| 1867.30 | 1867.30 USD Mn | 1449.60 USD Mn | 1186.00 USD Mn | 1036.60 USD Mn | 791.3 USD Mn | 539.5 USD Mn | 313.8 USD Mn |
| 1990.10 | 1990.10 USD Mn | 1563.60 USD Mn | 1261.10 USD Mn | 1092.20 USD Mn | 828.1 USD Mn | 567.1 USD Mn | 327.4 USD Mn |
| 2116.90 | 2116.90 USD Mn | 1693.00 USD Mn | 1337.90 USD Mn | 1142.40 USD Mn | 863.8 USD Mn | 593.8 USD Mn | 339.5 USD Mn |
Data Source: Wantstats Repository
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansGrowth Outlook
- The 2024] by Application portion of the Global Arrhythmia Monitoring Devices market [2016 market is on a steady long-term growth path. Segment value stands at roughly USD 7630 Mn in 1990.10 and is projected to reach USD 8087 Mn by 2116.90 — a gain of about 6% over the forecast period, translating to a CAGR in the low single digits.
- tachycardia segment accounted for the largest market share in the arrhythmia monitoring devices market, and is expected to reach USD 2116. 90 Million in 2024 from USD 1413.
- What the regional split looks like (1990.10): Tachycardia leads, holding roughly 26% of segment value — the single largest regional share. Bradycardia is the second-largest contributor. Atrial Fibrillation (A-fib), Ventricular Fibrillation (V-fib), Premature Ventricular Contractions (PVC), Conduction Disorders and Application_Others make up the remainder, in descending order.
- By 2116.90, Tachycardia alone is expected to reach USD 2117 Mn, with Bradycardia at USD 1693 Mn.
Market Dynamics
tachycardia segment accounted for the largest market share in the arrhythmia monitoring devices market, and is expected to reach USD 2116.90 Million in 2024 from USD 1413.70 Million in 2018. However, bradycardia segment is the fastest growing market, which is expected to grow at a CAGR of 7.32% during the forecast period 2019 - 2024.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



